Next |
home / stock / clnn / clnn message board
Subject | By | Source | When |
---|---|---|---|
$CLNN Looks pretty positive | tw0122 | investorshub | 05/08/2023 6:20:21 PM |
we got news | 81vette | investorshub | 05/03/2023 7:49:35 AM |
$CLNN Have a look at this | harry crumb | investorshub | 04/28/2023 8:55:42 PM |
$CLNN bulls and bears | 81vette | investorshub | 04/24/2023 1:44:10 AM |
$CLNN The gaining | skichic | investorshub | 04/23/2023 10:49:34 AM |
$CLNN bears and bulls | TheFinalCD | investorshub | 04/23/2023 1:14:31 AM |
short squeeze | skichic | investorshub | 04/22/2023 12:30:20 PM |
$CLNN MomentumIts trading | 81vette | investorshub | 04/15/2023 1:25:20 AM |
i.ll take 12 bucks per share | JUST 10-11-12 | investorshub | 03/08/2023 9:44:34 PM |
EF Hutton initiates coverage today on $CLNN with | CapGainsman | investorshub | 03/08/2023 4:35:51 PM |
12mms stacked,bid/demand growing,13k@1.21,could pop any min now | 81vette | investorshub | 02/28/2023 8:12:21 PM |
Over 3m shares short,some covering has to happen | 81vette | investorshub | 02/28/2023 8:00:36 PM |
Day1 of higher high/higher low,gotta love nabbing the | 81vette | investorshub | 02/28/2023 4:32:19 PM |
My Scanner telling me buy now,bulls back to | 81vette | investorshub | 02/28/2023 3:59:58 PM |
Oppenheimer has a buy rating of Overweight for | skichic | investorshub | 02/13/2023 11:14:50 PM |
Strange how $CLNN traded today. Fantastic news, huge | skichic | investorshub | 02/13/2023 11:13:00 PM |
Bills have to get paid,maybe done in after | 81vette | investorshub | 02/13/2023 7:11:58 PM |
ALL DAY FADER= ZZZZZZZZZ | TheFinalCD | investorshub | 02/13/2023 6:09:20 PM |
todays news>https://capedge.com/news/benzinga/30873738/clene-reports-new-data?fr | 81vette | investorshub | 02/13/2023 4:39:33 PM |
zero borrow>no shares available to short(float locked up),insider | 81vette | investorshub | 02/13/2023 4:27:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Clene Inc. Company Name:
CLNN Stock Symbol:
NASDAQ Market:
SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary...
Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today...
SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neurona...